Physician profile
Paul Kevin Linneman
NPI 1801362710
$1,613.71
in general payments reported to CMS, 2019-2025
13 companies · $683 in 2025
The $683 reported for 2025 was more than what 83% of Acute Care (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.57 · 2022: $249 · 2023: $570 · 2024: $75.78 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,329.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $421.06 | 2021-2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Solventum Corporation | $317.85 | 2025 | Activ.A.C., V.A.C. Veraflo, 3m Cavilon |
| Access Pro Medical, LLC | $185.75 | 2023 | Matriderm |
| Kci USA, INC. | $136.11 | 2021-2022 | |
| Vericel Corporation | $124.58 | 2023 | Nexobrid |
| Medline Industries Lp | $118.02 | 2025 | |
| Molnlycke Health Care US, LLC | $102.78 | 2023 | Mepilex Border Sacrum, Tortoise Turning & Positioning System, Mlnlycke Z-Flex Fluidized Heel Boot |
| Smith+Nephew, INC. | $59.61 | 2025 | Biobrane |
| Polynovo North America LLC | $50.16 | 2024 | Novosorb Btm |
| Philips North America LLC | $31.96 | 2023 | |
| Avita Medical Americas, LLC | $25.62 | 2024 | |
| Endo USA, INC. | $24.37 | 2025 | Xiaflex |
| Abc Home Medical Supply, INC. | $15.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Linneman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.